drugset / Trial / NCT06823479
Towards Cure Via Only Ultra-short ICB in CSCC
Phase 2
Recruiting
41 enrolled
The Netherlands Cancer Institute
Amsterdam UMC, location VUmc · collabErasmus Medical Center · collabMaastricht University Medical Center · collabUMC Utrecht · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to determine whether cutaneous squamous cell carcinoma patients can be cured using only immunotherapy, without surgery or radiotherapy.
Timeline
- Start
- 2025-05-14
- Primary completion
- 2029-02
- Completion
- 2029-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ipilimumab | Monoclonal antibody | 1 mg/kg | Intravenous |
| Subject | Nivolumab | Monoclonal antibody | 3 mg/kg | Intravenous |